Your browser doesn't support javascript.
loading
Influence of medical insurance schemes and charity assistance projects on regular prophylaxis treatment of the boys with severe haemophilia A in China.
Li, Z; Wu, J; Zhao, Y; Liu, R; Li, K; Zhou, Y; Wu, R; Yang, R; Zhang, X; Lian, S; Hu, Q; Li, X; Gu, J; Zhou, R; Sun, J; Li, C; Xu, W; Poon, M-C; Xiao, J.
Afiliação
  • Li Z; Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Wu J; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
  • Zhao Y; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Liu R; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
  • Li K; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhou Y; Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Wu R; Department of Hematology, Beijing Children's Hospital, Capital Medical University, Beijing, China.
  • Yang R; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
  • Zhang X; Shandong Center of Hemophilia Diagnosis and Treatment, Jinan, China.
  • Lian S; Department of Hematology, Dalian Municipal Central Hospital, Dalian Medical University, Dalian, China.
  • Hu Q; Department of Pediatric Hematology, Tongji Hospital, Tongji Medical College Huazhong, University of Science & Technology, Wuhan, China.
  • Li X; Department of Pediatric Hematology and Oncology, Chengdu Women and Children's Center Hospital, Chengdu, China.
  • Gu J; Department of Hematology, Subei people's Hospital, Yangzhou, China.
  • Zhou R; Department of Hematology, Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
  • Sun J; Department of Hematology, NanFang Hospital, Southern Medical University, Guangzhou, China.
  • Li C; Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen, China.
  • Xu W; Department of Hematology, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
  • Poon MC; Division of Hematology/Hematologic Malignancies, Department of Medicine, University of Calgary-Foothills Hospital, Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program, Calgary, Canada.
  • Xiao J; Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Haemophilia ; 24(1): 126-133, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29148258
ABSTRACT

OBJECTIVE:

To explore the influence of medical insurance policy and charity assistance projects on the uptake and discontinuation of regular prophylaxis treatment in Chinese severe haemophilia A children.

METHODOLOGY:

This retrospective study was conducted on children with severe haemophilia A, who received FVIII prophylaxis treatment at 12 haemophilia centres in China from 1 November 2007 to 31 May 2013.

RESULTS:

The average duration of prophylaxis treatment received by haemophilia children significantly increased from 16.7 weeks in 2008 to 32.8 weeks in 2012 (P < .001). The main reason for prophylaxis acceptance included dissatisfaction with previous "on-demand" regimens, availability of improved local medical insurance policies and patient/family awareness of haemophilia. The main reason for subsequent discontinuation of prophylaxis was economic instability. The upper limit of insurance was up to RMB 150 000/y (~USD 22 000/y) for 80.1% of the insured patients and would be sufficient to cover the continuous low-dose prophylaxis regimen. However, for many patients the burden of out-of-pocket copayment cost represented a risk for poor adherence to regular prophylaxis. In about two third of the patients, the annual out-of-pocket copayment cost amounted to >50% of their average annual disposable income. Many patients therefore required assistance from the charity assistance projects, but nonadherence remained prevalent.

CONCLUSION:

Medical insurance policy and charity assistance projects helped haemophilia children to accept and continue prophylaxis regimens. It was the proportion of the out-of-pocket copayment cost rather than the upper limit of insurance reimbursement that restricted long-term regular low-dose prophylaxis in China.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator VIII / Hemofilia A Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2018 Tipo de documento: Article